Experimental Validation: In vitro experiments confirmed that Diosgenin inhibits GC cell proliferation, migration, and invasion, while Western blot analysis validated its modulation of key proteins (MDM2, p53, and PLK1). Here, MDM2 is linked to gastric cancer.